Changes of blood viscosity in patients treated with 5-fluorouracil--a link to cardiotoxicity?

Autor: Cwikiel M; Department of Oncology, University Hospital Lund, Sweden., Persson SU, Larsson H, Albertsson M, Eskilsson J
Jazyk: angličtina
Zdroj: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 1995; Vol. 34 (1), pp. 83-5.
DOI: 10.3109/02841869509093643
Abstrakt: Cardiotoxicity is a serious but relatively unknown side-effect of treatment with 5-fluorouracil (5-FU). The underlying mechanism of 5-FU cardiotoxicity has not been defined. The aim of the present study was to determine whether hemorheological factors might in part explain 5-FU cardiotoxicity. Changes of blood and plasma viscosity, fibrinogen and hematocrit were studied in 11 patients treated by 5-FU. The study showed a decrease in blood and plasma viscosity during treatment with 5-FU, probably caused by a decrease of plasma fibrinogen. Reversible cardiotoxic effects were demonstrated in four patients.
Databáze: MEDLINE